Hyponatraemia, fever, vomiting, severe abdominal pain, and weight loss associated with omeprazole

New Zealand Medical Journal

Volumn 118, Issue 1208, 2005, Pages

  Colls, Barry M ^a,b   Menzies, Oliver ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CILAZAPRIL; INSULIN; OMEPRAZOLE; PROTON PUMP;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ESOPHAGUS INJURY; FEMALE; FEVER; HUMAN; HYPERTENSION; HYPONATREMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALLORY WEISS SYNDROME; NAUSEA; NODULAR GOITER; VOMITING; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; MIDDLE AGED;

ABDOMINAL PAIN; FEMALE; FEVER; HUMANS; HYPONATREMIA; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; VOMITING; WEIGHT LOSS;

EID: 17144410787     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Moynihan R. Drug spending in North America rose by 11% in 2003. BMJ. 2004,328:727.
2. Pharmaceutical Management Agency, New Zealand. Annual Review, Alimentary drug expenditure. 2003:20-1.
3. Durst RY, Pipek R, Levy Y. Hyponatraemia caused by omeprazole treatment. Am J Med. 1994;97:400-1.
4. Landray MJ, Ringrose T, Ferner RE, Arnold IR. Pyrexia, anaemia and acute renal failure secondary to omeprazole. Postgrad Med J. 1998;74:416-22.
5. Shiba S, Sugiura K, Ebata A, et al. Hyponatraemia with consciousness disturbance caused by omeprazole administration. Dig Dis Sci. 1996;41:1615-17.
6. Personal correspondence. Centre for adverse reactions monitoring (CARM) database, Dunedin. May 2004.
7. Myers RP, McLaughlin K, Hollomby DJ. Acute interstitial nephritis due to omeprazole. Am J Gastroenterol. 2001;96:3428-31.
8. Castot A, Bidault I, Dahan R, Efthymious ML. Bilan des effets inattendus et toxiques de l'omeprazole (Mopral) reapportes aux centres regionaux de pharmacovigilance, au cours des 22 premiers mois de commercialisation. Therapies. 1993;48:469-74.
9. Rosholm J-U, Nybo H, Ranberg KA, et al. Hyponatraemia in very old nonhospitalised people. Drugs Aging. 2002;19:685-93.
10. Barone JA, Horn JR. Experts opinion: appreciating the pharmacologic differences among proton pump inhibitors. Available online. URL: http://www.medscape.com/viewarticle/461183_8 Accessed January 2005.